Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 175 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

 		Early Breast Cancer Phase3 Australia
Canada
China
Germany
Hong Kong
India
Israel
Mexico
Portugal
South Korea
Taiwan
Turkey (Türkiye)
United States
View all
 NCT05827081

DFT383 in Pediatric Participants With Nephropathic Cystinosis

 		Nephropathic Cystinosis Phase1, Phase2 United States NCT06910813

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

 		Immunoglobulin A Nephropathy United States NCT06952426

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

 		Ankylosing Spondylitis South Korea NCT06905288

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

 		Alzheimer Disease, Mild Cognitive Impairment Phase1 France
Spain 		NCT05469360

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

 		Juvenile Psoriatic Arthritis Phase1 United States NCT06751238

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

 		ANCA Associated Vasculitis (AAV) Phase2 Brazil
Israel
Japan
Saudi Arabia
Singapore
Switzerland
United Kingdom
United States
View all
 NCT06868290

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

 		Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors Phase1, Phase2 Australia
Canada
Czechia
Denmark
France
Germany
Israel
Italy
Japan
Singapore
South Korea
Taiwan
United States
View all
 NCT06726148

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

 		Hidradenitis Suppurativa United Arab Emirates NCT06785675

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

 		Relapsing Multiple Sclerosis (RMS) Phase3 Puerto Rico
United States 		NCT06869785